Ortin Global Limited Cash Flow Conversion Efficiency
Ortin Global Limited cash flow conversion efficiency. Based on the latest financial reports, Ortin Global Limited (ORTINGLOBE) has a cash flow conversion efficiency ratio of -0.597x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-7.75 Million ≈ $-83.86K USD) by net assets (Rs13.00 Million ≈ $140.55K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Ortin Global Limited (2021–2026)
Cash flow conversion efficiency of Ortin Global Limited from 2021 to 2026. This chart illustrates how Ortin Global Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ORTINGLOBE stock price and chart for real-time trading data and today's change.
Ortin Global Limited Cash Flow Conversion Ratio Explained
Ortin Global Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Ortin Global Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ortin Global Limited ranked by their cash flow conversion efficiency. Also see ORTINGLOBE company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Chariot Oil & Gas Limited
LSE:CHAR
|
-0.061x |
|
Spectra7 Microsystems Inc
V:SEV
|
-0.792x |
|
ARMATURA S.A.
RO:ARM
|
-0.001x |
|
Global Opportunities Trust Ord
LSE:GOT
|
N/A |
|
GOLDREA RES CORP.
F:GOJ1
|
N/A |
|
Debock Industries Limited
NSE:DIL
|
0.006x |
|
Sky Gold Corp
V:SKYG
|
-0.256x |
|
Tracsis Plc
LSE:TRCS
|
0.106x |
Annual Cash Flow Conversion Efficiency for Ortin Global Limited (2021–2026)
The table below shows the annual cash flow conversion efficiency of Ortin Global Limited from 2021 to 2026. Review ORTINGLOBE FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs12.37 Million ≈ $133.79K |
Rs-5.62 Million ≈ $-60.76K |
-0.454x | -118.87% |
| 2025-03-31 | Rs19.77 Million ≈ $213.86K |
Rs-4.10 Million ≈ $-44.37K |
-0.207x | +87.76% |
| 2024-03-31 | Rs28.24 Million ≈ $305.39K |
Rs-47.87 Million ≈ $-517.71K |
-1.695x | -7171.33% |
| 2023-03-31 | Rs108.65 Million ≈ $1.17 Million |
Rs-2.53 Million ≈ $-27.39K |
-0.023x | -111.89% |
| 2022-03-31 | Rs109.57 Million ≈ $1.18 Million |
Rs21.48 Million ≈ $232.29K |
0.196x | -87.66% |
| 2021-03-31 | Rs113.56 Million ≈ $1.23 Million |
Rs180.34 Million ≈ $1.95 Million |
1.588x | -- |
About Ortin Global Limited
Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quin… Read more